Principal Investigator for the following Trial:
New York Methodist Cardiology Clinical Studies
Active Studies
TOPCAT
Project Start Day: 28 Feb 2007
Status: Active.
Principle Investigator: Dr. John Heitner
NYM# 78354
“Treatment Of Preserved Cardiac function heart failure with an Aldosterone anTagonist.”
SOLSTICE
Project Start Day: 25 Aug 2009
Status: Active.
Principle Investigator: Dr. John Heitner
NYM# 126194
“A randomized, double-blind, placebo-controlled study to evaluate the safety of 12 weeks of dosing with GW856553 and its effects on inflammatory markers, infarct size, and cardiac function in subjects with myocardial infarction without ST segment elevation Short title: SOLSTICE, A Study Of LoSmapimod Treatment on Inflammation and InfarCt SizE”
DETERMINE
Project Start Day: 23 Jul 2009
Status: Active.
Principle Investigator: Dr. John Heitner
NYM# 122659
“Defibrillators to Reduce Risk by Magnetic Resonance Imaging Evaluation (DETERMINE)”
ALECARDIO
Project Start Day: 10 Mar 2010
Status: Active
Principle Investigator: Dr. Sorin Brener.
NYM# 158014
“Cardiovascular outcomes study to evaluate the potential of aleglitazar to reduce cardiovascular risk in patients with a recent acute coronary syndrome (ACS) event and type 2 diabetes mellitus (T2D)”
TRILOGY-ACS
Project Start Day: 27 Apr 2010
Status: Active
Principle Investigator: Dr. Sorin Brener.
WIRB-Approved
“A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome (ACS) Subjects with Unstable Angina/Non-ST-Elevation Myocardial Infarction (UA/NSTEMI) Who are Medically Managed – The TRILOGY ACS Study”
TTR
Project Start Day: 20 May 2010
Status: Active
Principle Investigator: Dr. John Heitner.
NYM# 169405
“Title Retrospective Study to Assess the Quality of Anticoagulation with Warfarin in Patients with Nonvalvular Atrial Fibrillation”
TAO
Project Start Day: 15 Jul 2010
Status: Active
Principle Investigator: Dr. John Heitner.
NYM# 171960
“A randomized, double-blind, triple-dummy trial to compare the efficacy of otamixaban with Unfractionated Heparin + eptifibatide, in patients with Unstable angina/Non ST segment Elevation Myocardial infarction scheduled to undergo an early invasive strategy (TAO)”
PROMISE
Project Start Day: 01 Jun 2010
Status: Active
Principle Investigator: Dr. John Heitner.
NYM# 171270
“Prospective Multi-center Imaging Study for Evaluation of Chest Pain (PROMISE)”
RESOLUTE-US
Project Start Day: 28 Jan 2008
Status: Active
Principle Investigator: Dr. Sorin Brener.
NYM# 100901
“A Clinical Evaluation of the Medtronic Endeavor® Resolute Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries with a Reference Vessel Diameter of 2.25 mm to 4.2 mm”.
DESERT
Project Start Day: 16 Jul 2009
Status: Active
Principle Investigator: Dr. Sorin Brener.
NYM# 126049
“DESERT (Drug Eluting Stent Event Registry of Thrombosis) The National DES Thrombosis Registry”
Completed Studies
PLATO
Project Start Day: 22 Mar 2005
Status: closed
Principle Investigator: Dr. Terrence Sacchi
NYM# 78439
“A Randomized, Double-blind, Parallel Group, Phase 3, Efficacy and Safety Study of AZD6140 Compared with Clopidogrel for Prevention of Vascular Events in Patients with Non-ST or ST Elevation Acute Coronary Syndromes (ACS).”
ENDEAVOR IV
Project Start Day: 6 Sep 2005
Status: Closed for enrollment
Principle Investigator: Dr. Terrence Sacchi
NYM# 78437
“A Randomized Controlled Trial of the Medtronic Endeavor Drug (ABT-578) Eluting Coronary Stent System versus the Taxus Paclitaxel-eluting coronary Stent System in DE NOVO Native Coronary Artery Lesions The Endeavor IV Trial”
TIMI 43- AVANTGARDE
Project Start Day: 28 Feb 2007
Status: Closed
Principle Investigator: Dr. Terrence Sacchi
NYM# 78434
“A randomized, double-blind, parallel-group, placebo-controlled,multinational clinical trial to evaluate the efficacy of Aliskiren and Valsartan versus placebo in lower levels on NT-proBNP in stabilized patients post acute coronary syndrome”
THE VOLCANO REGISTRY TRIAL:
Project start day: 15 Feb 2005
Status: closed.
Principle Investigator: Dr. Terrence Sacchi
NYM# 264
JUPITER
Project Start Day: 22 Mar 2005
Status: closed
Principle Investigator: Dr. Terrence Sacchi
NYM# 292
“A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of Rosuvastatin (CRESTOR®) 20 mg in the Primary Prevention of Cardiovascular Events Among Subjects with Low Levels of LDL-Cholesterol and Elevated Levels of C-Reactive Protein”
EARLY-ACS
Project Start Day: 24 Mar 2005
Status: closed
Principle Investigator: Dr. Terrence Sacchi
NYM# 78436
“Early Glycoprotein IIb/IIIa Inhibition in Non-ST-segment Elevation Acute Coronary Syndrome: A Randomized, Placebo-Controlled Trial Evaluating the Clinical Benefits of Early Front-loaded Eptifibatide in the Treatment of Patients with Non-ST-segment Elevation Acute Coronary Syndrome (EARLY ACS)”
(MERLIN) – TIMI 36
Project Start Day: 30 Nov 2004
Status: closed.
Principle Investigator: Dr. Terrence Sacchi
NYM# 257
“Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST elevation
Acute Coronary Syndromes”
(TRITON)- TIMI 38
Project Start Day: 26 Jan 2005
Status: closed
Principle Investigator: Dr. Terrence Sacchi
NYM# 78438
“A comparison of CS-747 and Clopidogrel in ACS Syndrome subjects who are to undergo Percutaneous Coronary Intervention”
RISE TRIAL
Project start day: 25 Jan 2006
Status: closed.
Principle Investigator: Dr. Terrence Sacchi
NYM# 336
“RISE Trial A Clinical Evaluation of the StarClose™ Vascular Closure System
A Prospective, Multi-Center, Registry to Evaluate Safety and Efficacy of the Starclose™ Vascular Closure System in Patients Who Are Ambulated Early Post Diagnostic Catheterization”.
AMEthyst
Project start day: 22 Mar 2005
Status: closed.
Principle Investigator: Dr. Terrence Sacchi
NYM# 78435
“The Assessment of the Medtronic AVE Interceptor Saphenous Vein Graft Filter
REVEAL
Project Start Day: 28 Jun 2006
Status: Closed
Principle Investigator: Dr. John Heitner
NYM# 78358
“Randomized, Multi-Center, Double-blind, Placebo Controlled Trial of the Effects of Erythropoietin on Infarct Size and Left Ventricular Remodeling in Survivors of Large Myocardial Infarctions”.
ROCKET-AF
Project Start Day: 25 Apr 2007
Status: Closed for enrollment.
Principle Investigator: Dr. John Heitner
NYM# 78357
“ROCKET: A Prospective, Randomized, Double-Blind, Double-Dummy, Parallel-Group, Multicenter, Event-Driven, Non-inferiority Study Comparing the Efficacy and Safety of Once-Daily Oral Rivaroxaban (BAY 59-7939) With Adjusted-Dos Oral Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Subjects with Non-Valvular Atrial Fibrillation”
CORDIS ELITE
Project Start Day: 28 May 2008
Status: Closed for enrollment
Principle Investigator: Dr. Sorin Brener.
NYM# 87636
“A Prospective, Single Blind, Randomized, Multi-Center, Study Comparing The CYPHER® ELITE™ to The CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems”
TRACER
Project Start Day: 28 Jul 2008
Status: closed for enrollment
Principle Investigator: Dr. Sorin Brener.
Approved By WIRB
“A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects With Acute Coronary Syndrome: Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome.”
PROTECT-(MEDTRONIC)
Project Start Day: 28 Jul 2008
Status: Closed for enrollment
Principle Investigator: Dr. Sorin Brener.
Approved By WIRB
“Patient Related Outcomes with Endeavor versus Cypher stenting Trial”
PROTECT-CA (MEDTRONIC)
Project Start Day: 19 Feb 2008
Status: Closed for enrollment
Principle Investigator: Dr. Sorin Brener.
Approved By WIRB
“Patient Related OuTcomes with Endeavor versus Cypher stenting Trial –
PROTECT Continued Access Post Marketing Surveillance Trial”
INNOVATE-PCI
Project Start Day: 24 Sep 2008
Status: closed
Principle Investigator: Dr. Sorin Brener.
NYM# 95477
A Randomized, Double-Blind, Active-Controlled Trial to Evaluate
“Intravenous and Oral PRT060128, a Selective and Reversible P2Y12-Receptor Inhibitor, vs. Clopidogrel, as a Novel Antiplatelet Therapy in Patients Undergoing Non-Urgent Percutaneous Coronary Intervention (INNOVATE-PCI)”
MIP-BP23, (ZEUS)
Project Start Day: 6 Jul 2007
Status: Closed
Principle Investigator: Dr. Lijun Weng.
NYM# 78554
“Open-Label, Phase 2 Study of the Safety and Efficacy of ß-Methyl-p- [123I]-Iodophenyl-Pentadecanoic Acid (Iodofiltic Acid I 123) for Identification of Ischemic Myocardium Using Single Photon Emission Computed Tomography (SPECT) in Adults with Symptoms Consistent with Acute Coronary Syndrome (ACS)”
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- which of the following equations represents photosynthesis
- find words with the following letters
- words that contain the following letters
- words with the following letters
- words using the following letters
- words with the following letters scrabble
- words containing the following letters
- determine the range of the following graph
- find the zeros in the following equation
- principal investigator responsibilities
- simulate the execution of the following function
- list the equipment required to measure the following and name the type of sampli